Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP932179.RA2e82iRQAwUaL6tDi0kaW9A1dmx90BFLcMmZGoBOfmDk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP932179.RA2e82iRQAwUaL6tDi0kaW9A1dmx90BFLcMmZGoBOfmDk130_assertion type Assertion NP932179.RA2e82iRQAwUaL6tDi0kaW9A1dmx90BFLcMmZGoBOfmDk130_head.
- NP932179.RA2e82iRQAwUaL6tDi0kaW9A1dmx90BFLcMmZGoBOfmDk130_assertion description "[Interestingly, HDAC1 association with Sp1 and with the P-Rex1 promoter were much weaker in metastatic prostate cancer PC-3 cells than in non-metastatic prostate cancer cells, and HDAC inhibitors only had very modest stimulatory effects on P-Rex1 promoter activity and P-Rex1 expression in PC-3 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP932179.RA2e82iRQAwUaL6tDi0kaW9A1dmx90BFLcMmZGoBOfmDk130_provenance.
- NP932179.RA2e82iRQAwUaL6tDi0kaW9A1dmx90BFLcMmZGoBOfmDk130_assertion evidence source_evidence_literature NP932179.RA2e82iRQAwUaL6tDi0kaW9A1dmx90BFLcMmZGoBOfmDk130_provenance.
- NP932179.RA2e82iRQAwUaL6tDi0kaW9A1dmx90BFLcMmZGoBOfmDk130_assertion SIO_000772 21636851 NP932179.RA2e82iRQAwUaL6tDi0kaW9A1dmx90BFLcMmZGoBOfmDk130_provenance.
- NP932179.RA2e82iRQAwUaL6tDi0kaW9A1dmx90BFLcMmZGoBOfmDk130_assertion wasDerivedFrom befree-20150227 NP932179.RA2e82iRQAwUaL6tDi0kaW9A1dmx90BFLcMmZGoBOfmDk130_provenance.
- NP932179.RA2e82iRQAwUaL6tDi0kaW9A1dmx90BFLcMmZGoBOfmDk130_assertion wasGeneratedBy ECO_0000203 NP932179.RA2e82iRQAwUaL6tDi0kaW9A1dmx90BFLcMmZGoBOfmDk130_provenance.